InspireMD Historical Income Statement
| NSPR Stock | USD 1.85 0.13 6.57% |
Historical analysis of InspireMD income statement accounts such as Total Operating Expenses of 14.4 M can show how well InspireMD performed in making a profits. Evaluating InspireMD income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of InspireMD's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining InspireMD latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether InspireMD is a good buy for the upcoming year.
InspireMD |
About InspireMD Income Statement Analysis
InspireMD Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to InspireMD shareholders. The income statement also shows InspireMD investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
InspireMD Income Statement Chart
InspireMD Income Statement is one of the three primary financial statements used for reporting InspireMD's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of InspireMD revenue and expense. InspireMD Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, InspireMD's Income Tax Expense is relatively stable compared to the past year. As of 04/25/2024, Total Other Income Expense Net is likely to grow to about 1.1 M, while Selling General Administrative is likely to drop slightly above 8 M. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of InspireMD. It is also known as InspireMD overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Total Revenue
Total revenue comprises all receipts InspireMD generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most accounts from InspireMD's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Income Tax Expense is relatively stable compared to the past year. As of 04/25/2024, Total Other Income Expense Net is likely to grow to about 1.1 M, while Selling General Administrative is likely to drop slightly above 8 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 3.7M | 4.1M | 4.4M | 3.1M | Research Development | 5.2M | 7.8M | 8.0M | 4.3M |
InspireMD income statement Correlations
Click cells to compare fundamentals
InspireMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InspireMD income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 42K | 160K | 157K | 28K | 25.2K | 23.9K | |
| Selling General Administrative | 5.2M | 6.1M | 7.4M | 8.4M | 11.1M | 8.0M | |
| Other Operating Expenses | 13.5M | 12.9M | 19.2M | 23.9M | 27.1M | 16.0M | |
| Operating Income | (9.8M) | (10.4M) | (14.7M) | (18.7M) | (20.9M) | (19.8M) | |
| Ebit | (9.8M) | (10.4M) | (14.7M) | (18.7M) | (20.9M) | (19.8M) | |
| Ebitda | (9.7M) | (10.2M) | (14.6M) | (18.5M) | (20.7M) | (19.6M) | |
| Total Operating Expenses | 10.6M | 10.5M | 15.5M | 19.8M | 22.7M | 14.4M | |
| Income Before Tax | (10.0M) | (10.5M) | (14.9M) | (18.5M) | (19.9M) | (20.8M) | |
| Net Income | (10.0M) | (10.5M) | (14.9M) | (18.5M) | (19.9M) | (20.9M) | |
| Total Other Income Expense Net | (200K) | (160K) | (157K) | 250K | 1.0M | 1.1M | |
| Depreciation And Amortization | 158K | 151K | 161K | 188K | 232K | 182.6K | |
| Total Revenue | 3.7M | 2.5M | 4.5M | 5.2M | 6.2M | 3.3M | |
| Gross Profit | 756K | 83K | 754K | 1.1M | 1.8M | 1.0M | |
| Research Development | 3.0M | 2.2M | 5.2M | 7.8M | 8.0M | 4.3M | |
| Cost Of Revenue | 3.0M | 2.4M | 3.7M | 4.1M | 4.4M | 3.1M | |
| Selling And Marketing Expenses | 2.4M | 2.1M | 2.9M | 3.7M | 3.9M | 3.3M | |
| Net Income From Continuing Ops | (10.0M) | (10.5M) | (14.9M) | (18.5M) | (19.9M) | (20.9M) | |
| Net Income Applicable To Common Shares | (10.0M) | (10.5M) | (14.9M) | (18.5M) | (21.3M) | (22.3M) | |
| Net Interest Income | (200K) | (160K) | (157K) | 250K | 1.3M | 1.4M | |
| Reconciled Depreciation | 158K | 151K | 161K | 188K | 232K | 191.7K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for InspireMD Stock analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 0.256 | Quarterly Revenue Growth 0.716 | Return On Assets (0.37) | Return On Equity (0.70) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.